Primary Health Properties (PHP)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 93.05 |
|---|---|
| 52-week range | 88.30 – 109.60 |
| Return, 1 month / 3 months | +3.4% / −0.9% |
| Return, 1 year / 3 years | +6.8% / +33.3% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 17.1% |
| Worst drawdown (1 year) | -15.8% |
| Average daily value traded | 981.69M GBX |
| Dividend yield | 7.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Primary Health Properties is a real estate investment trust that owns and manages healthcare premises, chiefly doctors' surgeries and health centres, across the United Kingdom and Ireland. Its buildings are let to general practitioners, primary care providers and related healthcare operators, who occupy them under long leases. The company is based in the United Kingdom and concentrates on the primary care property market, collecting rent from medical tenants rather than developing or trading property.
Primary Health Properties trades under the code PHP on the London Stock Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Primary Health Properties (PHP) trades on the London Stock Exchange in UK. It last closed at GBX 93.05 on 27 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 653 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.8% and over the last three months it fell 0.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 0.8% | ||
| From 52-week high | -14.1% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.9% | ||
| 6-month return | 3.6% | ||
| 12-month return, skipping the last month | 3.2% | ||
| Stability (higher is calmer) | 88 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 17.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.8% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 981.69M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 7.8% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | +2.5% |
|---|---|
| 1 month | +3.4% |
| 3 months | −0.9% |
| 6 months | +3.6% |
| 1 year | +6.8% |
| 3 years | +33.3% |
| 5 years | −15.0% |
Signals
| 50-day / 200-day average | 90.99 / 92.32 |
|---|---|
| Golden / death cross (60 days) | Death, 19 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.45 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Oct 2026 | GBP 0.0183 |
| 2 Jul 2026 | GBP 0.0183 |
| 26 Mar 2026 | GBP 0.0183 |
| 29 Jan 2026 | GBP 0.0183 |
| 9 Oct 2025 | GBP 0.0178 |
| 3 Jul 2025 | GBP 0.0178 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.